Document and Entity Information
Document and Entity Information | Jul. 24, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jul. 24, 2024 |
Entity Registrant Name | Viking Therapeutics, Inc. |
Entity Central Index Key | 0001607678 |
Entity Emerging Growth Company | false |
Entity File Number | 001-37355 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 46-1073877 |
Entity Address, Address Line One | 9920 Pacific Heights Blvd |
Entity Address, Address Line Two | Suite 350 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 704-4660 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.00001 per share |
Trading Symbol | VKTX |
Security Exchange Name | NASDAQ |